BioCurex, Inc.(fka BOCX)

[enos]

Did you ever watch deal or no deal? Bocx like other emerging biotechs has a constant need for cash to continue. They need ABT to provide it or enter into other agreements or borrowing with its dillution. Products developed but not in the market place produce no revenue. Bocx needs a source of cash. Until they get it the stock price will remain low.